Skip to main content
Top
Published in: Documenta Ophthalmologica 2/2013

01-04-2013 | Original Research Article

Full-field electroretinography under general anesthesia in retinoblastoma

Authors: Ramya Sachidanandam, S. Krishnakumar, Lingam Gopal, Joan M. O’Brien, Vikas Khetan, Parveen Sen

Published in: Documenta Ophthalmologica | Issue 2/2013

Login to get access

Abstract

Purpose

To investigate the electrical responses of the retina in retinoblastoma (RB), by recording full-field electroretinography (ERG) under general anesthesia.

Methods

The ERG was recorded using Ephios hand-held portable ERG system, according to International Standards for Clinical Electrophysiology of Vision. Forty-eight eyes of 43 cases and 33 eyes of 33 controls were enrolled. The cases were classified based on international intraocular retinoblastoma classification (IIRC). Forty-eight eyes of cases were divided into 30 cases with active RB and 18 cases with regressed RB.

Results

The amplitudes of a- and b-waves were decreased as compared to controls in all subgroups. The implicit times of all RB patients from group A to C differed statistically from controls (p value < 0.05) except for single-flash rod response. The ERG waveforms in group E eyes were non-recordable. The comparison of ERG parameters between active and regressed groups (IIRC groups A and B) was statistically insignificant. Single case follow-up of unilateral RB after systemic chemotherapy showed improvement in amplitudes compared to baseline parameters.

Conclusions

Reduced amplitudes and delayed implicit times were noted in advanced disease. The ERG of RB cases did not follow any specific pattern of waveform. ERG appears to be a dynamic parameter to observe changes following treatment for RB. Although ERG is not a diagnostic test for RB, it can be used as a complementary test to assess the residual retinal function in RB eyes.
Literature
2.
go back to reference Marmor MF, Fulton AB, Holder GE, Miayke Y, Briell M, Bach M (2008) ISCEV standard for full-field clinical electroretinography. Doc Ophthalmol 118:69–77PubMedCrossRef Marmor MF, Fulton AB, Holder GE, Miayke Y, Briell M, Bach M (2008) ISCEV standard for full-field clinical electroretinography. Doc Ophthalmol 118:69–77PubMedCrossRef
3.
go back to reference Brodie SE, Gobin YP, Dunkel IJ, Kim JW, Abramson DH (2009) Persistence of retinal function after selective ophthalmic artery chemotherapy infusion for retinoblastoma. Doc Ophthalmol 119:13–22PubMedCrossRef Brodie SE, Gobin YP, Dunkel IJ, Kim JW, Abramson DH (2009) Persistence of retinal function after selective ophthalmic artery chemotherapy infusion for retinoblastoma. Doc Ophthalmol 119:13–22PubMedCrossRef
4.
go back to reference Abramson DH, Dunkel IJ, Brodie SE, Marr B, Gobin YP (2010) Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery). Ophthalmology 117:1623–1629PubMedCrossRef Abramson DH, Dunkel IJ, Brodie SE, Marr B, Gobin YP (2010) Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery). Ophthalmology 117:1623–1629PubMedCrossRef
5.
go back to reference Lubiński W, Zajaczek S, Sych Z, Penkala K, Palacz O, Lubiński J (2002) Electroretinographic changes in the inner retinal layers of the retained eyes of patients with sporadic unilateral retinoblastoma. Ophthalmic Genet 23:99–107PubMedCrossRef Lubiński W, Zajaczek S, Sych Z, Penkala K, Palacz O, Lubiński J (2002) Electroretinographic changes in the inner retinal layers of the retained eyes of patients with sporadic unilateral retinoblastoma. Ophthalmic Genet 23:99–107PubMedCrossRef
6.
go back to reference Shields CL, Shields JA (2006) Basic understanding of current classification and management of retinoblastoma. Curr Opin Ophthalmol 17:228–234PubMedCrossRef Shields CL, Shields JA (2006) Basic understanding of current classification and management of retinoblastoma. Curr Opin Ophthalmol 17:228–234PubMedCrossRef
7.
go back to reference Shields CL, Palamar M, Sharma P, Ramasubramanian A, Leahey A, Meadows AT, Shields JA (2009) Retinoblastoma regression patterns following chemoreduction and adjuvant therapy in 557 tumors. Arch Ophthalmol 127:282–290PubMedCrossRef Shields CL, Palamar M, Sharma P, Ramasubramanian A, Leahey A, Meadows AT, Shields JA (2009) Retinoblastoma regression patterns following chemoreduction and adjuvant therapy in 557 tumors. Arch Ophthalmol 127:282–290PubMedCrossRef
8.
go back to reference Robanus-Maandag E, Dekker M, van der Vaik M, Carrozza ML, Jeanny JC, Dannenberg JH, Berns A, te Riele H (1998) p107 Is a suppressor of retinoblastoma development in pRb-deficient mice. Genes Dev 12:1599–1609PubMedCrossRef Robanus-Maandag E, Dekker M, van der Vaik M, Carrozza ML, Jeanny JC, Dannenberg JH, Berns A, te Riele H (1998) p107 Is a suppressor of retinoblastoma development in pRb-deficient mice. Genes Dev 12:1599–1609PubMedCrossRef
9.
go back to reference Johnson DA, Zhang J, Frase S, Wilson M, Rodriguez-Galindo C, Dyer MA (2007) Neuronal differentiation and synaptogenesis in retinoblastoma. Cancer Res 67:2701–2711PubMedCrossRef Johnson DA, Zhang J, Frase S, Wilson M, Rodriguez-Galindo C, Dyer MA (2007) Neuronal differentiation and synaptogenesis in retinoblastoma. Cancer Res 67:2701–2711PubMedCrossRef
10.
go back to reference Nork TM, Schwartz TL, Doshi HM, Millechia LL (1995) Retinoblastoma cell of origin. Arch Ophthalmol 113:791–802PubMedCrossRef Nork TM, Schwartz TL, Doshi HM, Millechia LL (1995) Retinoblastoma cell of origin. Arch Ophthalmol 113:791–802PubMedCrossRef
11.
go back to reference Gallie BL, Campbell C, Delvin H, Duckett A, Squire JA (1999) Development basis of retinal-specific induction or cancer by RB mutation. Cancer Res 59(7 Suppl):1731s–1735sPubMed Gallie BL, Campbell C, Delvin H, Duckett A, Squire JA (1999) Development basis of retinal-specific induction or cancer by RB mutation. Cancer Res 59(7 Suppl):1731s–1735sPubMed
12.
go back to reference Poche R, Reese BE (2009) Retinal horizontal cells: challenging paradigms of neural development and cancer biology. Development 136:2141–2151PubMedCrossRef Poche R, Reese BE (2009) Retinal horizontal cells: challenging paradigms of neural development and cancer biology. Development 136:2141–2151PubMedCrossRef
13.
go back to reference Tremblay F, Parkinson JE (2003) Alteration of electroretinographic recordings when performed under sedation of halogenate anesthesia in a pediatric population. Doc Ophthalmol 107:271–279PubMedCrossRef Tremblay F, Parkinson JE (2003) Alteration of electroretinographic recordings when performed under sedation of halogenate anesthesia in a pediatric population. Doc Ophthalmol 107:271–279PubMedCrossRef
14.
go back to reference Andreasson S, Tornqvist K, Ehinger B (1993) Full field electroretinograms during general anesthesia in normal children compared to examination with topical anesthesia. Acta Ophthalmol 71:491–495 Andreasson S, Tornqvist K, Ehinger B (1993) Full field electroretinograms during general anesthesia in normal children compared to examination with topical anesthesia. Acta Ophthalmol 71:491–495
Metadata
Title
Full-field electroretinography under general anesthesia in retinoblastoma
Authors
Ramya Sachidanandam
S. Krishnakumar
Lingam Gopal
Joan M. O’Brien
Vikas Khetan
Parveen Sen
Publication date
01-04-2013
Publisher
Springer-Verlag
Published in
Documenta Ophthalmologica / Issue 2/2013
Print ISSN: 0012-4486
Electronic ISSN: 1573-2622
DOI
https://doi.org/10.1007/s10633-012-9368-4

Other articles of this Issue 2/2013

Documenta Ophthalmologica 2/2013 Go to the issue

EditorialNotes

Editor’s comment